The Effect of Intraoperative Hypotension on Postoperative Renal Function

Most studies defined IOH as a MAP less than 65 mmHg [14, 15]. Relative thresholds based on a drop from preoperative BP were found to be no more predictive for AKI than this absolute threshold of 65mmHg. There was also no clinically important association of preoperative BP with postoperative AKI. BP management under anesthesia is therefore now recommended by some to be based on intraoperative BP without regard to preoperative BP [14].

The autoregulatory curve is however shifted to the right in patients with significant preoperative hypertension [16, 17]. Patients with poorly controlled hypertension may therefore need to be treated with higher BP goals because aggressive treatment of hypertension in this group of patients is associated with an increase in the serum creatinine concentration [18]. In a multicenter study in septic ICU patients, there was a direct correlation of relative hypotension with AKI [19].

The Perioperative Quality Initiative consensus statement on intraoperative BP regarding the risks and outcomes for elective surgery also clearly highlighted that even brief durations of MAP less than 60–70mmHg are harmful during non-cardiac surgery [20]. However, there is significant variation in the definition of IOH in the literature [21]. Reported systolic BP thresholds vary from as low as 55mmHg [22] to as high as 110mmHg [23, 24]. When studies use a relative BP drop from preoperative levels instead of absolute values, there is a weaker association with detecting postoperative adverse events [21].

AKI has historically been defined as a small elevation in serum creatinine, but new biomarkers are under investigation as rapidly obtainable and more accurate predictors of AKI [25]. Twenty-four-hour urine creatinine clearance is a more accurate test for AKI than a rise in serum creatinine, but it is difficult to obtain in routine clinical practice. A rise in serum creatinine from baseline has therefore been considered to be a reasonable substitute. Trying to standardize AKI using serum creatinine has however serious flaws because creatinine is affected by factors other than AKI like volume overload, nutrition, steroids, and muscle trauma. Several biomarkers for AKI like tissue inhibitor of metalloproteinase-2, insulin-like growth factor binding protein-7, and neutrophil gelatinase-associated lipocalin have the potential to substantially improve the diagnostic approach to AKI in the future [26, 27]. AKI is defined differently by different organizations. The Kidney Disease: Improving Global Outcomes (KDIGO) definition [28] differs from the Risk, Injury, Failure, Loss, and End-Stage Renal Disease (RIFLE), the AKI Network (AKIN), and the Society of Thoracic Surgeons (STS) criteria [29]. RIFLE uses Glomerular Filtration Rate (GFR) criteria in addition to serum creatinine and urine output criteria. GFR criteria were abandoned in the AKIN and KDIGO definitions. The Risk, Injury, and Failure categories of the RIFLE definition were replaced by AKIN and KDIGO stages 1, 2, and 3. In AKIN stage 1, an absolute rise in serum creatinine of more than 26.4 μmol/l was added to the relative increase of 150–200% in serum creatinine compared to baseline. This increase in serum creatinine of more than 26.4 μmol/l in AKIN stage 1 was replaced by an absolute rise in serum creatinine of more than 26.5 μmol/l in stage 1 of the KDIGO definition. Both in the RIFLE and KDIGO definitions, the increase in creatinine is defined to occur within 7 days, which contrasts with the 48 h used in the AKIN definition. In stage 3 of the AKIN and KDIGO definitions, the need for renal replacement therapy (RRT) was added. The categories Loss and End-Stage Kidney disease or equivalent (outcome) categories from the RIFLE definition were removed from the AKIN and KDIGO definitions. Urine output criteria are similar in RIFLE, AKIN, and KDIGO definitions.

AKIN and KDIGO detect more AKI patients than the RIFLE criteria, and this explains the large heterogeneity in the literature [30]. The current STS definition of acute renal failure is a threefold increase in serum creatinine, a creatinine greater than 4mg/dl, or the initiation of dialysis. This definition fails to identify the vast majority of patients with AKI [31].

Independent risk factors for perioperative AKI include advanced age, pre-existing hypertension, active congestive heart failure, chronic kidney disease, insulin-dependent diabetes mellitus, peripheral vascular disease, the presence of ascites, high body mass index, pulmonary disease, and the African American race (Table 1) [32]. Patients with sepsis and systemic inflammatory response syndrome are also at increased risk, and it appears that there is a microvascular component involved in in the development of AKI [33]. Venous congestion in patients with right ventricular dysfunction is another risk factor for AKI. While increased intravascular volume is usually protective against AKI in patients with venous congestion from congestive heart failure, it is associated with an increased risk of AKI [34]. Procedures associated with AKI are cardiac, thoracic, orthopedic, vascular, urologic, and ear, nose, and throat operations. A prediction model has been developed and validated for postoperative AKI after non-cardiac surgery [35]. Prevention of IOH in these particularly at-risk patient groups and surgical interventions is therefore very important. Serum creatinine should also be measured postoperatively in these at-risk patients because perioperative AKI often goes unrecognized [36].

Outcome studies looking at the association of IOH and AKI usually measure mean arterial pressure (MAP). This is the most reliable method of identifying true IOH because systolic and diastolic pressures are more susceptible to measurement errors resulting from wave summation artifacts. The MAP is the most robust measurement and should be used to guide the management of intraoperative BP [37]. BP cuffs need to be of the correct size for the patient to be able to accurately identify IOH. A cuff that is too large will underestimate BP, and a cuff that is too small will overestimate BP. Measurement errors are especially common in obese patients with large arms when standard cylindrical cuffs are used [38]. Newer non-invasive continuous BP monitors have become available that measure BP in the digital arteries via a finger cuff. A recent study in vascular surgical patients found the use of ClearSight is a viable alternative to invasive BP measurement via a radial arterial line [39].

Adequate hydration and maintaining optimal preload to the left ventricle are crucial for maintaining organ perfusion. Fluid management should be individualized and optimized for every single patient [40]. Dehydration has been clearly implicated in the pathophysiology of postoperative AKI [41, 42]. Preoperative volume status is unfortunately not always given sufficient attention in clinical practice and should be thoroughly evaluated especially prior to emergency operations. A recent multicenter prospective randomized trial showed a higher rate of AKI when restrictive fluid management was used in patients at risk for complications during major abdominal surgery [43]. Consideration also needs to be given to maintaining the normal composition of the circulating blood. Clinicians need to understand the Starling forces that affect the movement of fluid across a semipermeable membrane like the glomerulus. Anesthesiologists should not extrapolate results obtained from studies in intensive care patients with sepsis to their patients with significant hemorrhage in the operating room. The pathophysiological origin of the hypotension in these two groups of patients is very different. It is therefore not surprising that the same therapeutic intervention has a different outcome in both of these different clinical scenarios.

Most drugs used to induce general anesthesia cause some degree of vasodilation. Dilation of the venous system results in reduced left ventricle preload and then reflected in reduced MAP and cardiac output. Administration of vasopressors like phenylephrine has been shown to increase rather than decrease cardiac output by raising cardiac preload back to normal levels in patients with anesthesia-induced hypotension [44]. While vasopressors can improve perfusion in hypotension caused by vasodilation from anesthetic drugs, they should however not be used to treat hypotension due to dehydration or hypovolemia [45].

Keeping MAP above 65 mmHg does not necessarily guarantee sufficient organ perfusion and maintenance tissue oxygen delivery. Clinicians should not automatically assume that organ perfusion is adequate simply because BP goals are met. When managing BP intraoperatively, an appropriate balance needs to be maintained between vasopressor medication and intravenous fluids to ensure that perfusion remains acceptable. Clinical signs of peripheral perfusion like skin color, capillary refill time, temperature of the extremities, and urine output need to be assessed continuously throughout the procedure. Skin pallor, slow refill time, and poor urine output should be treated with intravenous fluid rather than vasopressor medications. In patients with poor ejection fraction, a beta-1 agonist may need to be used in combination with intravenous fluids. The patient needs to be assessed for clinical signs of sympathetic nervous system activation like tachycardia, narrow pulse pressure, pallor, diaphoresis, and mydriasis throughout the procedure because these findings can be indicators of significant hypovolemia. Positioning changes may also profoundly affect venous return and cardiac output [46]. Steep reverse Trendelenburg position may result in IOH due to decreased venous return which may need to be treated with vasopressor medications.

The notion that maintaining MAP above 65 mmHg without considering indictors of cardiac output may not be sufficient was confirmed in a recent prospective trial in major non-cardiac surgery that failed to show a reduction in AKI despite a 60% reduction in hypotensive time with a MAP less than 65 mmHg [47]. The patients in the group with a mean BP target of greater than 75mmHg received significantly higher cumulative doses of vasopressors. Cardiac output was not measured in this study, and excessive use of vasopressor medications instead of intravenous fluid in the high BP group could explain this unexpected finding.

Careful clinical assessment therefore needs to be employed when administering vasopressors. In a recent retrospective cohort study in elderly patients undergoing non-cardiac surgery, high vasopressor use was associated with postoperative AKI, independent of hypotension identified from anesthetic records [48]. A high vasopressor dose in this study was defined as a cumulative dose of greater than 20 mg of metaraminol, norepinephrine, or phenylephrine or greater than 10mg epinephrine. Every 5mg increase of the total dose of vasopressors used during the surgery was associated with an 11% increase in the odds of AKI.

Goal-directed fluid therapy utilizing dynamic indices of intravascular fluid volume like stroke volume variation have become widely used in high-risk patients. Measurements derived from this pulse contour analysis-based technology have been well validated when compared to values obtained from a pulmonary artery catheter [49]. A systematic review of goal-directed fluid therapy on renal function in critically ill patients concluded that this may be an effective method to prevent AKI in critically ill patients [50]. A prospective, randomized, controlled, and blinded study in patients undergoing major elective non-cardiac surgery failed however to demonstrate a benefit of goal-directed therapy in the prevention of AKI [51]. The detailed physiologic data analyzed in this study did nevertheless confirm the expert consensus that even relatively short periods of IOH requiring vasopressors contribute to perioperative AKI. A recent trial in open radical cystectomy patients unexpectedly found an even higher rate of AKI in the goal-directed fluid management group than in the standard fluid management group [52]. The goal-directed group had lower urine output and lower intraoperative and 6-h recovery room fluid intake. The reduced fluid given to the goal- directed group may have caused the increased rate of AKI. Failure of this new strategy to consistently prevent AKI in the perioperative setting may be due to insufficient understanding of the factors that affect stroke volume variation. Increased airway pressure due to positive pressure ventilation, increased positive end expiratory pressure, bronchospasm, and raised intra-abdominal pressure increase stroke volume variation [53‐55]. Hypovolemia can therefore be present despite an apparently normal stroke variation. Intravenous fluids may consequently need to be administered on occasion despite a normal stroke volume variation to prevent AKI.